Sloan Sheldon

Spyre Therapeutics, Inc. · Chief Medical Officer

Sloan Sheldon is listed in public filings as officer: Chief Medical Officer. This Sloan Sheldon insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Spyre Therapeutics, Inc. (SYRE). Investors use Sloan Sheldon's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Spyre Therapeutics, Inc.SYRE$08.3k sharesSellJun 3, 2026$625.0K8.3k shares$75.00--
Spyre Therapeutics, Inc.SYRE$229k8.3k sharesGrant / ExerciseJun 3, 2026$228.8K8.3k shares$27.46--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Spyre Therapeutics, Inc.SYRE$2.2M78.3k sharesGrant / ExerciseMay 1, 2026$2.2M78.3k shares$27.46--
Spyre Therapeutics, Inc.SYRE$4.0M57k sharesSellMay 1, 2026$1.5M21.3k shares$69.53--
Spyre Therapeutics, Inc.SYRE$2.6M37.4k sharesSellMay 1, 2026$1.4M19.7k shares$70.61--
Spyre Therapeutics, Inc.SYRE$1.2M15.8k sharesSellMay 1, 2026$932.0K12.8k shares$72.94--
Spyre Therapeutics, Inc.SYRE$403k5.5k sharesSellMay 1, 2026$763.8K10.4k shares$73.74--
Spyre Therapeutics, Inc.SYRE$2.0M28.6k sharesSellMay 1, 2026$628.1K8.8k shares$71.56--
Spyre Therapeutics, Inc.SYRE$30k400 sharesSellMay 1, 2026$377.4K5.1k shares$74.60--
Spyre Therapeutics, Inc.SYRE$0400 sharesSellMay 1, 2026$30.1K400 shares$75.37--
Spyre Therapeutics, Inc.SYRE$08k sharesSellApr 1, 2026$397.9K8k shares$50.00--
Spyre Therapeutics, Inc.SYRE$172k8k sharesGrant / ExerciseApr 1, 2026$172.4K8k shares$21.66--
Spyre Therapeutics, Inc.SYRE$4.3M140k sharesGrant / ExerciseJan 9, 2026$4.3M140k shares$30.61--
Spyre Therapeutics, Inc.SYRE$2.1M95.5k sharesGrant / ExerciseJan 15, 2025$2.1M95.5k shares$21.66--
Spyre Therapeutics, Inc.SYRE$11M400k sharesGrant / ExerciseOct 1, 2024$11.0M400k shares$27.46--